Effects of milrinone for right ventricular failure after left ventricular assist device implantation
被引:0
作者:
S. Kihara
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
S. Kihara
Akihiko Kawai
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Akihiko Kawai
Takuya Fukuda
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Takuya Fukuda
Noboru Yamamoto
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Noboru Yamamoto
Shigeyuki Aomi
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Shigeyuki Aomi
Hiroshi Nishida
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Hiroshi Nishida
Masahiro Endo
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Masahiro Endo
Hitoshi Koyanagi
论文数: 0引用数: 0
h-index: 0
机构:Department of Cardiovascular Surgery,
Hitoshi Koyanagi
机构:
[1] Department of Cardiovascular Surgery,
[2] Heart Institute of Japan,undefined
[3] Tokyo Women’s Medical University,undefined
[4] 8-1 Kawada-cho,undefined
[5] Shinjuku-ku,undefined
[6] Tokyo 162-8666,undefined
[7] Japan,undefined
来源:
Heart and Vessels
|
2002年
/
16卷
关键词:
Key words Left ventricular assist device;
Right ventri-cular failure;
Phosphodiesterase inhibitor;
Pulmonary hypertension;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Right ventricular failure after left ventricular assist device implantation sometimes requires additional mechanical right ventricular support. The effectiveness of nitrates, prostaglandin, or nitric oxide inhalation in such cases has already been reported. However, there are few reports on the administration of phosphodiesterase inhibitor for right ventricular failure after left ventricular assist device implantation. We report two patients with right ventricular failure after left ventricular assist device implantation successfully treated with milrinone. Both had residual pulmonary hypertension due to high pulmonary vascular resistance after left ventricular assist device implantation. However, intravenous milrinone caused a significant reduction in pulmonary vascular resistance and an increase in left ventricular assist device flow. Milrinone acts as both an inotropic agent and a direct vasodilator, and thus may avoid the need for mechanical support for right ventricular failure due to residual pulmonary hypertension after left ventricular assist device implantation.